A detailed history of Empire Life Investments Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Empire Life Investments Inc. holds 317,891 shares of MRK stock, worth $31.3 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares
317,891
Previous 366,433 13.25%
Holding current value
$31.3 Million
Previous $45.4 Million 20.42%
% of portfolio
2.25%
Previous 2.88%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$111.15 - $128.97 $5.4 Million - $6.26 Million
-48,542 Reduced 13.25%
317,891 $36.1 Million
Q2 2024

Jul 31, 2024

SELL
$123.8 - $132.96 $12.6 Million - $13.6 Million
-102,029 Reduced 21.78%
366,433 $45.4 Million
Q1 2024

Apr 30, 2024

SELL
$113.24 - $131.95 $1.19 Million - $1.38 Million
-10,475 Reduced 2.19%
468,462 $61.8 Million
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $1.28 Million - $1.39 Million
-12,780 Reduced 2.6%
478,937 $52.2 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $361,766 - $401,755
-3,514 Reduced 0.71%
491,717 $50.6 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $222,107 - $242,087
2,045 Added 0.41%
495,231 $57.1 Million
Q1 2023

May 08, 2023

SELL
$102.94 - $114.86 $5.91 Million - $6.6 Million
-57,458 Reduced 10.43%
493,186 $52.5 Million
Q4 2022

Feb 02, 2023

SELL
$87.44 - $112.11 $15.7 Million - $20.2 Million
-179,872 Reduced 24.62%
550,644 $61.1 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1 Million - $1.13 Million
11,868 Added 1.65%
730,516 $62.9 Million
Q2 2022

Aug 03, 2022

SELL
$83.49 - $94.64 $5.68 Million - $6.43 Million
-67,980 Reduced 8.64%
718,648 $65.5 Million
Q1 2022

May 11, 2022

SELL
$73.51 - $82.4 $771,487 - $864,788
-10,495 Reduced 1.32%
786,628 $64.5 Million
Q4 2021

Feb 09, 2022

BUY
$72.28 - $90.54 $853,482 - $1.07 Million
11,808 Added 1.5%
797,123 $61.1 Million
Q3 2021

Nov 09, 2021

BUY
$71.68 - $78.83 $9.14 Million - $10 Million
127,488 Added 19.38%
785,315 $59 Million
Q2 2021

Aug 04, 2021

BUY
$70.31 - $77.77 $17.4 Million - $19.3 Million
248,174 Added 60.58%
657,827 $51.2 Million
Q1 2021

Apr 29, 2021

SELL
$68.86 - $81.11 $886,710 - $1.04 Million
-12,877 Reduced 3.05%
409,653 $31.6 Million
Q4 2020

Feb 09, 2021

SELL
$71.77 - $79.65 $3.05 Million - $3.38 Million
-42,473 Reduced 9.13%
422,530 $34.6 Million
Q3 2020

Nov 05, 2020

BUY
$73.18 - $82.95 $2.48 Million - $2.81 Million
33,905 Added 7.86%
465,003 $38.6 Million
Q2 2020

Aug 03, 2020

BUY
$70.42 - $80.13 $9.64 Million - $11 Million
136,845 Added 46.51%
431,098 $33.3 Million
Q1 2020

Apr 23, 2020

BUY
$63.36 - $87.82 $297,221 - $411,963
4,691 Added 1.62%
294,253 $22.6 Million
Q4 2019

Jan 21, 2020

BUY
$77.58 - $87.54 $127,774 - $144,178
1,647 Added 0.57%
289,562 $26.3 Million
Q3 2019

Oct 25, 2019

BUY
$76.08 - $82.93 $1.31 Million - $1.43 Million
17,247 Added 6.37%
287,915 $24.2 Million
Q2 2019

Aug 20, 2019

BUY
$69.84 - $81.59 $3.2 Million - $3.74 Million
45,853 Added 20.4%
270,668 $22.7 Million
Q1 2019

Apr 17, 2019

SELL
$69.58 - $79.36 $12,663 - $14,443
-182 Reduced 0.08%
224,815 $18.7 Million
Q4 2018

Feb 04, 2019

SELL
$65.24 - $75.71 $2.95 Million - $3.42 Million
-45,187 Reduced 16.72%
224,997 $17.2 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $1.06 Million - $1.24 Million
-18,315 Reduced 6.35%
270,184 $19.2 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $69,687 - $81,876
1,371 Added 0.48%
288,499 $17.5 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $272,585 - $316,821
5,349 Added 1.9%
287,128 $15.6 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $72,113 - $86,111
1,397 Added 0.5%
281,779 $15.9 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $5.53 Million - $5.95 Million
94,322 Added 50.69%
280,382 $18 Million
Q2 2017

Aug 14, 2017

BUY
N/A
186,060
186,060 $11.9 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Empire Life Investments Inc. Portfolio

Follow Empire Life Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Life Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Empire Life Investments Inc. with notifications on news.